Carl J. Baldick

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy #

Daniel J. Tenney, Ronald E. Rose, Carl J. Baldick et al. · Hepatology · 2009 · 816 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Entecavir resistance is rare in nucleoside naïve patients with hepatitis B

Richard J. Colonno, Ronald E. Rose, Carl J. Baldick et al. · Hepatology · 2006 · 348 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Two-Year Assessment of Entecavir Resistance in Lamivudine-Refractory Hepatitis B Virus Patients Reveals Different Clinical Outcomes Depending on the Resistance Substitutions Present

Daniel J. Tenney, Ronald E. Rose, Carl J. Baldick et al. · Antimicrobial Agents and Chemotherapy · 2006 · 239 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Sequence specificity of mRNA N6-adenosine methyltransferase

Tünde Csépány, Amy Lin, Carl J. Baldick et al. · Journal of Biological Chemistry · 1990 · 188 citations · Full text

Life Sciences, Genetics, Molecular Biology +12

Inhibition of Hepatitis B Virus Polymerase by Entecavir

David R. Langley, Ann W. Walsh, Carl J. Baldick et al. · Journal of Virology · 2007 · 187 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17